Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
Authors:
- Christina BluemelCBChristina Bluemel
- Domenico RubelloDRDomenico Rubello
- Ken HerrmannKHKen Herrmann
- 1 June 2016
- journal article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 37 (6) , 567-569
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Prostate Cancer, Version 1.2016Journal of the National Comprehensive Cancer Network, 2016
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- 18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphyEuropean Journal of Radiology, 2012
- Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)European Journal of Radiology, 2012
- [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Dual Tracer 11C-Choline and FDG-PET in the Diagnosis of Biochemical Prostate Cancer Relapse After Radical TreatmentMolecular Imaging and Biology, 2009
- Treatment failure after primary and salvage therapy for prostate cancerCancer, 2007
- 10-Year Outcome for Men With Localized Prostate Cancer Treated With External Radiation Therapy:: Results of a Cohort StudyJournal of Urology, 2004
- Treatment of Organ Confined Prostate Cancer with Third Generation Cryosurgery: Preliminary Multicenter ExperienceJournal of Urology, 2003